昊帆生物(301393.SZ)发布前三季度业绩，归母净利润9923.83万元，增长3.01%

Core Viewpoint - Haofan Bio (301393.SZ) reported a significant increase in revenue and a modest rise in net profit for the first three quarters of 2025, indicating positive growth trends in its financial performance [1] Financial Performance - The company's operating revenue for the first three quarters reached 435 million yuan, representing a year-on-year growth of 32.47% [1] - The net profit attributable to shareholders of the listed company was 99.24 million yuan, showing a year-on-year increase of 3.01% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 81.27 million yuan, reflecting a year-on-year decrease of 2.79% [1] - Basic earnings per share stood at 0.93 yuan [1]